Evidence map›Paper›PMID 41652216›Full record

ArticleCurrent microbiology2026

Synergistic Antibacterial Activity of Quercetin-Functionalized Magnetic Nanoparticles Combined with Ciprofloxacin on Pathogenic Pseudomonas Aeruginosa Via Targeting Virulence, Efflux Pump, and Adhesion-Associated Genes and Molecular Docking Analysis.

Farahnaz Harouni Navroudi, Reyhaneh Kouchakinejad, Ali Bazri Chenijani, Shiva Kouhsari Chalehsarayi, Fatemeh Najari, Hanieh Bejari, Hossein Zahmatkesh, Najmeh Ranji, Behnam Rasti, Mohammad Nikpassand and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Current microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Zinc oxide-bacteriophage synergistic combination for dual-mode antibacterial activity against multidrug-resistant Escherichia coli.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Farahnaz Harouni NavroudiDepartment of Biology, Ra.C, Islamic Azad University, Rasht, Iran.
Reyhaneh KouchakinejadDepartment of Chemistry, Ra.C, Islamic Azad University, Rasht, Iran.
Ali Bazri ChenijaniDepartment of Biology, Ra.C, Islamic Azad University, Rasht, Iran.
Shiva Kouhsari ChalehsarayiDepartment of Biology, Ra.C, Islamic Azad University, Rasht, Iran.
Fatemeh NajariDepartment of Biology, Ra.C, Islamic Azad University, Rasht, Iran.
Hanieh BejariDepartment of Biology, Ra.C, Islamic Azad University, Rasht, Iran.
Hossein ZahmatkeshDepartment of Biology, Ra.C, Islamic Azad University, Rasht, Iran.
Najmeh RanjiDepartment of Biology, Ra.C, Islamic Azad University, Rasht, Iran.
Behnam RastiDepartment of Microbiology, La.C, Islamic Azad University, Lahijan, Iran.
Mohammad NikpassandDepartment of Chemistry, Ra.C, Islamic Azad University, Rasht, Iran. mohammad.nikpassand@iau.ac.ir.
Mahdi ShahriarinourDepartment of Biology, Ra.C, Islamic Azad University, Rasht, Iran. ma.shahriarinour@iau.ac.ir.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biofilm formation and the activity of efflux pumps are major contributors to antibiotic resistance in clinical strains of Pseudomonas aeruginosa and significantly enhance the pathogenicity of this bacterium. Functionalization of metal nanoparticles with plant-derived flavonoids, particularly when combined with conventional antibiotics, represents a promising strategy for overcoming antimicrobial resistance. In the present study, we investigated the synergistic inhibitory effects of quercetin-functionalized magnetic nanoparticles (Fe

Indexed as

Anti-Bacterial AgentsCiprofloxacinMagnetite NanoparticlesPseudomonas aeruginosaQuercetinBacterial AdhesionBacterial ProteinsBiofilmsDrug Resistance, BacterialDrug SynergismHumansMicrobial Sensitivity TestsMolecular Docking SimulationPseudomonas InfectionsVirulenceVirulence FactorsAnti-Bacterial AgentsBacterial ProteinsCiprofloxacinMagnetite NanoparticlesQuercetinVirulence Factors

Identifiers

PMID41652216

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.